EP3283043A1 - Sealing device for making it possible to collect a composition, packaging assembly comprising such a sealing device, collection and packaging methods - Google Patents
Sealing device for making it possible to collect a composition, packaging assembly comprising such a sealing device, collection and packaging methodsInfo
- Publication number
- EP3283043A1 EP3283043A1 EP16719282.2A EP16719282A EP3283043A1 EP 3283043 A1 EP3283043 A1 EP 3283043A1 EP 16719282 A EP16719282 A EP 16719282A EP 3283043 A1 EP3283043 A1 EP 3283043A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- container
- composition
- closure
- closing device
- sampling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B7/00—Closing containers or receptacles after filling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2068—Venting means
- A61J1/2075—Venting means for external venting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2079—Filtering means
- A61J1/2082—Filtering means for gas filtration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D47/00—Closures with filling and discharging, or with discharging, devices
- B65D47/04—Closures with discharging devices other than pumps
- B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
- B65D47/12—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having removable closures
- B65D47/14—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages having removable closures and closure-retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1425—Snap-fit type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
Definitions
- Clogging device for sampling a packaging composition comprising such a closure device, sampling and packaging methods
- the present invention relates to a closure device for sampling for administration, enterally or nasally, or for external use of compositions in the pharmaceutical, cosmetic and food.
- the invention also relates to a packaging assembly comprising such a closure device as well as methods for packaging and sampling compositions.
- Syrups or oral solutions packaged in multi-dose vials with screw caps are known. As soon as the bottle is opened, the outside air enters the container and contaminates the contents.
- antimicrobial preservatives be added to the liquid solutions thus conditioned.
- the main antimicrobial preservatives validated and used for liquid forms are alcohol, benzoic acid and parabens. Alcohol and benzoic acid can not be used in all liquid formulations, especially in pediatric preparations or for the treatment of persons with hepatic disease. There remains the parabens, already largely added to pharmaceuticals, cosmetics and food. However, a potential accumulation of these parabens in the body, could lead to hormonal disturbances. The use of parabens is so far controversial. The current trend is the elimination of preservatives in all products, especially those intended for children or those with contraindications to preservatives. However, for lack of validated alternative, the use of these antimicrobial preservatives remains valid.
- EP 0 960 616 discloses an elastomeric stopper for insertion into the neck of a vial and having a sealing membrane capable of self-sealing.
- No. 4,614,515 describes a device for capping a vial, in particular allowing the content to be removed by means of a needle syringe for parenteral administration.
- FR 2 928 539 discloses an interfacing device for connecting a parenteral needle syringe and a drug-containing perforating bottle.
- FR 2 993 174 relates to a device for securing the distribution of a liquid contained in a bottle, comprising a section reducer having a first orifice capable of receiving a syringe, an intermediate piece having a second orifice and intended to cap the reducer of section so that said first and second holes are facing each other and a closing means of the first and / or second orifices.
- EP 2,266,523 discloses a vial adapter comprising a valve that can occupy an open position allowing communication between a syringe and the interior of the vial to allow the introduction of a liquid into the vial or the collection of liquid. out of the bottle, and a closed position preventing any fluid communication.
- WO 2012/061353 discloses a system for filling a fluid in bottles and distributing the fluid from the bottles, comprising two different valves, each being adapted for one of these two functions.
- WO 2011/027207 relates to a connection device between different medical accessories to allow and control the transfer of fluid from one accessory to another.
- EP 2,601,987 discloses a device comprising two non-return valves for connecting a bottle, a syringe and a catheter.
- the present invention provides a closure device for taking a composition intended for enteral or nasal administration, or for external use, contained in a container, characterized in that 'it comprises :
- a nozzle defining an internal passage opening onto an opening, configured to allow a connection to a sampling member such as an enteral syringe,
- a non-return valve associated with said nozzle, configured to open when the contents of the container are taken with the aid of the sampling member
- the contamination of the composition contained in the container is avoided, which makes it possible to avoid or reduce the use of preservatives in the compositions, especially those intended for children or persons with a pathology such as hepatic or allergic pathology.
- composition is meant any liquid solution, emulsion, semi-liquid solution, colloidal solution, or semi-pasty product, especially a gel, for (e) pharmaceutical, food or cosmetic use.
- the air intake port allows the entry of air into the container, in particular simultaneously with a sample of composition in the container.
- the tip may have at least partially a substantially conical shape, in particular with a conicity of about 6%, being preferably of the "lockable standard cone” or “luer lock cone” type.
- the tip advantageously constitutes a secure and sealed connection member for a composition removal member for enteral administration or external use.
- the sampling member can be screwed onto the end piece so as to secure and seal the connection clogging.
- the tip comprises means for fixing, in particular the screwing of the sampling member, for example a thread, outer or inner. Compatibility with only the organs of sampling and administration enterally or externally, avoids the risk of sampling oral solution or not compulsorily sterile with a syringe for parenteral route.
- the non-return valve may include a seat and a sealing membrane resting on said seat and may have an annular shape. It may comprise an annular constriction on the waterproofing membrane to facilitate its deformation.
- the waterproofing membrane may be made of a polymeric material, especially a flexible material, used in the manufacture of devices for medical, food or cosmetic use, for example an elastomeric or silicone material.
- the filter may be made of a hydrophobic material intended to reduce bacterial contamination, for example having an average pore diameter of less than 0.3 ⁇ , for example equal to 0.22 ⁇ .
- the closure device according to the invention may comprise a plate intended to be in contact with the interior of the container and having at least one aperture for the passage of air and at least one aperture for the passage of liquid.
- the filter can then cover said at least one aperture for the passage of air, which can be fixed, in particular by gluing or welding, to said plate.
- the non-return valve can be positioned on the plate so as to close off said at least one aperture for the passage of liquid.
- the closure device according to the invention may comprise fixing means on the container.
- These fixing means may comprise a fixing skirt, in particular internally threaded, arranged to attach to a neck of the container, by screwing and / or latching.
- the fastening means may comprise a tamper evident relief configured to prevent the closure device from being removed from the container once it is secured to the container.
- the fixing means advantageously comprise a sealing skirt arranged to come into sealed internal contact with the neck of the container.
- the closure device according to the invention may comprise a closure member, the closure member being preferably connected to the rest of the device of the invention. capping by a flexible link, such as a film hinge.
- the closure member which can form a cover, makes it possible to close the closure device and in particular to close the end piece and the air intake opening or ports.
- the closure member may be provided with a tamper-evident means (tamper-evident means), proof that the device and therefore the composition has never been used.
- tamper-evident means proof that the device and therefore the composition has never been used.
- the closure device according to the invention may comprise an upper part and a lower part assembled together, in particular by snapping, said upper and lower parts together defining when assembled, an area for the passage of air, an intermediate zone for the maintaining the non-return valve, and an area for the passage of liquid.
- the upper part may comprise the nozzle and said at least one air intake port. It may comprise, on an internal face, a sealing lip intended to bear against the non-return valve, in particular on said annular shrinkage of the non-return valve.
- the upper part makes it possible to fix the sampling member.
- the lower part may include the tray. It is preferably in at least partial contact with the composition and can be attached to the bottle, comprising the means for attachment to the container.
- the entire closure device is advantageously made of thermoplastic material, by injection molding, the lower part and the closure member can be made in one piece.
- a packaging assembly for a composition intended for enteral administration or for external use comprising a container for packaging said composition, secured to a device for capping as defined above.
- Such an assembly may further comprise at least one sampling member, which is advantageously configured to allow enteral or external administration.
- This set can be packaged in an individual package totally or partially sterile or not, the container being filled with the composition to be dispensed.
- the invention makes it possible to reduce manufacturing costs compared to single-dose vials.
- the invention also makes it possible to increase the shelf life, after first opening of the container, of the composition.
- the concentration of preservatives in the composition can thus be reduced or even reduced to zero.
- the subject of the present invention is also, in combination with the foregoing, a process for taking a composition using a sampling device such as an enteral syringe in a container provided with a closure device such as defined above, including the following steps:
- the method may comprise the steps of opening the closure member before securing the sampling member to the tip and closing the closure member after removal of the sampling organ.
- the subject of the invention is also, in combination with the foregoing, a method of packaging in a container a composition intended for enteral administration or for external use, comprising the following steps:
- This packaging method may comprise the steps of associating with said container at least one sampling member such as a syringe and optionally to dispose the whole in an individual package, sterile or otherwise.
- FIG. 1 schematically and in perspective shows an example of a closure device according to the invention
- FIG. 2 represents, in axial section, schematic and partial, the closure device of FIG. 1,
- FIG. 3 is a diagrammatic view from below of the closure device of FIG. 1,
- FIG. 4 is a diagrammatic plan view of the closure device of FIG. 1, the upper part removed,
- FIG. 5 represents in axial section, schematically and partially, the closure device of FIG. 1, closed and fixed on the neck of a container
- FIG. 6 is a diagrammatic perspective view of the container provided with capping device of Figure 1, closed
- FIG. 7 schematically represents a packaging assembly comprising the container of FIG. 6 and a suitable sampling device
- FIGS. 8 and 9 schematically represent two steps of a method for packaging a composition in a closed container by a closure device according to the invention.
- Figures 10 to 13 illustrate, schematically, steps of a method of sampling a composition using the closure device according to the invention.
- the closure device 1, shown in Figures 1 to 5, is intended to be attached to a container 10, visible in particular in Figure 5 or 6.
- This container 10 contains a composition to be administered enterally or externally, of which the rate of preservatives is reduced or even zero.
- the closure device 1 comprises a dispensing nozzle 2 defining an internal passage 3 extending along a longitudinal axis X.
- the internal passage 3 opens onto an opening 4 forming the free end of the nozzle 2.
- the latter is configured to allow a connection to a sampling member such as an enteral syringe 20, visible in Figure 7.
- the closure device 1 further comprises a non-return valve 5 associated with the nozzle 2, configured to open when the contents of the container are taken with the aid of the sampling member, visible in particular in the figures 2, 4 and 5.
- the anti- return 5 prevents any return of liquid inside the container, and also prevents the entry of air in the absence of sampling member.
- the closure device 1 also comprises at least one air intake port 6, of which there are nine in this example. At least one antibacterial filter, aimed at reducing bacterial contamination, is associated with the orifices 6. Such a filter 7 systematically filters the air entering the container through the orifices 6, preventing contamination of the composition contained in the container.
- a filter 7 systematically filters the air entering the container through the orifices 6, preventing contamination of the composition contained in the container.
- the orifices 6 are for example each of circular shape.
- the tip 2 has at least partially a substantially conical shape about the longitudinal axis X, being slightly flared outwardly towards its opening 4, as can be seen in FIG. to be around 6%.
- the tip 2 may be a tip called “lockable standardized cone” or “cone luer lock”, the latter form with collar 8 locking further allowing a locking of the sampling member in the tip 2, of known way in itself.
- the non-return valve 5 is composed of a sealing membrane 27, made of a flexible polymer material, for example elastomer or silicone, having an annular shape around the X axis, as can be seen in particular in FIG.
- An annular necking 9 facilitates its deformation in the X axis of the container.
- the filter 7 is advantageously made of a hydrophobic material, so as to prevent the liquid from leaving the orifices 6.
- the filter 7 has, for example, an average pore diameter of less than 0.3 ⁇ .
- the closure device 1 illustrated has, as more particularly visible in Figure 3 or 5, a plate 11 intended to be in contact with the interior 73 of the container and having at least one aperture 12 for the passage of air and at least one aperture 13 for the passage of liquid.
- the openings 12 and 13 are distributed annularly around the central axis X, the openings 12 forming ring portions. located radially outwardly relative to the openings 13, also arranged in a ring portion about the longitudinal axis X.
- the number of openings 13 is six, this number can be reduced or increased without leaving the scope of the invention in particular be between three and six, so as to allow the passage of air without having to exert excessive traction on the syringe during sampling.
- the number of openings 12 is three, each opening 12 having separations 14 which can participate in maintaining the filter 7 underlying.
- the filter 7, or the filters 7, cover (s) the openings 12 for the passage of air and are fixed in particular by gluing or welding to the plate 11.
- a filter 7 is shown in FIG. 7 may be unique and have an annular shape of diameter and dimensions such that it covers all the openings 12 for the passage of air.
- the filters may be three in number as in this example, but only one filter 7 is shown in FIG. 4. Each filter 7 covers an aperture 12 for the passage of air.
- the angular extent of the air passage openings 12 is sufficient for the openings to overlap at least partially with at least a portion of the orifices 6.
- the upper and lower portions delimit between them an annular chamber where the air can circulate between the orifices 6 and the openings 12, when the air intake.
- the sealing membrane 27 is positioned in this example on the plate 11 so as to seal at rest, as can be seen in FIG. 4, the openings 13.
- the central, disc-shaped portion of the plate 11 thus forms the seat of the non-return valve 5.
- the sealing membrane is advantageously bonded, in particular by ultrasound.
- the closure device 1 further comprises fixing means 15 on the container.
- the fastening means 15 may comprise, as illustrated, a fastening skirt 16 having an internal thread 17 arranged to attach to a threaded collar externally of the container, as can be seen in FIG. 5.
- the fastening means 15 advantageously comprise a tamper evident relief 18, visible in FIGS. 2 and 5, configured to prevent the closure device 1 from being removed from the receptacle 10, once it is secured to the receptacle.
- this inviolability relief may be in the form of an annular groove, and the receptacle 10 may in turn comprise a fastening bead 21 complementary inviolability relief 18, on which the groove snaps to the end of the screwing of the fastening means.
- the fastening means 15 also comprise a sealing skirt 19 adapted to come into sealed internal contact with the neck of the container, as can be seen in particular in FIG. 5.
- the closure device 1 also comprises a closure member 25 whose role is to seal the opening 4 of the nozzle 2.
- the closure member 25 consists of a cover connected by a flexible link 26, such as a film hinge, at the base 100 of the closure device.
- the closure member 25 comprises a sealing lip 35 adapted to form the seal around the opening 4 of the nozzle 2, to prevent leakage when the closure device 1 is closed.
- a tamper-proof guarantee system before the first use is also provided.
- the cover has at its periphery, on its inner surface, an annular bead 31 adapted to snap into a corresponding groove 30 of the base 100, formed on a post protruding around the openings 6 of air intake.
- the base 100 comprises an upper part 50 and a lower part 60 assembled together, in this example by snap-fitting with complementary snap-on reliefs 51 and 52, respectively formed on the upper parts 50 and lower 60, in a form circular in a peripheral region thereof.
- the top 50 and bottom 60 together define when assembled three distinct areas.
- a first outer zone 61 defines the aforementioned annular chamber which allows the passage of air.
- a second zone 62 intermediate annular also allows the maintenance of the non-return valve 5 and a third zone 63, substantially cylindrical, allows the passage of liquid.
- the intermediate zone 62 prevents any communication between the zones 61 and 63.
- the upper part 50 of the closure device comprises the nozzle 2 and the air intake orifices 6.
- the upper part 50 has on an internal face 54 a sealing lip 55 bearing against the sealing membrane 27 of the non-return valve 5, on the annular necking 9. a depression is exerted, only the radially inner portion 4 to the annular necking of the membrane 27 is deformed.
- the dimensions of the upper part can be optimized so as to avoid stagnation of the liquid and avoid contamination during the next sampling.
- the lower part 60 comprises the plate 1 1 as well as the fixing means
- FIGS. 6 and 7 show an example of a packaging assembly 70, according to the invention.
- the container 10 consists of a glass bottle having a screw neck, for example of diameter 27 mm.
- the container or neck may be different without departing from the scope of the invention.
- the packaging assembly 70 comprises, in the example illustrated in FIG. 7, a sampling member 20 consisting of a luer lock type enteral syringe and an individual package 71 for packaging the assembly.
- the packaging 71 comprises in particular a plurality of sampling members 20.
- FIG. 8 illustrates steps of a packaging method according to the invention.
- the step illustrated in FIG. 8 consists in introducing the composition L into the container 10.
- the packaging method then comprises the step illustrated in FIG. 9, of fixing the closure device 1, in particular in this example by screwing on the neck 72 of the container 10.
- the packaging process may further comprise the step of associating with the container 10 provided with the closure device 1 at least one sampling member 20 and optionally disposing the whole in an individual package 71, totally or partially sterile or not as illustrated on Figure 7.
- FIGS. 10 to 13 show a method of taking the composition L with the aid of a sampling member.
- the closing member 25 of the closure device 1 is first opened, as illustrated in FIG. 10, and then the sampling member 20 is secured to the end piece 2, in this example by screwing, as illustrated in FIG. 11. Then, by returning the container, the desired amount of composition L with the sampling member 20, by pulling on the piston of the sampling member, as illustrated in Figure 12.
- the container may be equipped with a dip tube and / or be flexible elastic wall.
- An additional non-return valve can be positioned near the tip.
- Such an additional non-return valve for dry contact may be provided with a lockable standardized screwable cone specific for enteral administration.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mechanical Engineering (AREA)
- Ceramic Engineering (AREA)
- Hematology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Closures For Containers (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL16719282T PL3283043T3 (en) | 2015-04-17 | 2016-04-14 | Sealing device for making it possible to collect a composition, packaging assembly comprising such a sealing device, collection and packaging methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1553442A FR3035080B1 (en) | 2015-04-17 | 2015-04-17 | CLOSURE DEVICE FOR PERMITTING A SAMPLE OF A PACKAGING ASSEMBLY COMPOSITION COMPRISING SUCH A CLOGGING DEVICE, METHODS FOR COLLECTING AND PACKAGING |
PCT/EP2016/058194 WO2016166197A1 (en) | 2015-04-17 | 2016-04-14 | Sealing device for making it possible to collect a composition, packaging assembly comprising such a sealing device, collection and packaging methods |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3283043A1 true EP3283043A1 (en) | 2018-02-21 |
EP3283043B1 EP3283043B1 (en) | 2019-06-12 |
Family
ID=53758358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16719282.2A Active EP3283043B1 (en) | 2015-04-17 | 2016-04-14 | Sealing device for making it possible to collect a composition, packaging assembly comprising such a sealing device, collection and packaging methods |
Country Status (15)
Country | Link |
---|---|
US (1) | US11090226B2 (en) |
EP (1) | EP3283043B1 (en) |
JP (2) | JP2018512990A (en) |
KR (1) | KR20180008501A (en) |
CN (1) | CN107750225B (en) |
CA (1) | CA2982935A1 (en) |
ES (1) | ES2745278T3 (en) |
FR (1) | FR3035080B1 (en) |
HK (2) | HK1246256A1 (en) |
IL (1) | IL255082A0 (en) |
MX (1) | MX2017013325A (en) |
PL (1) | PL3283043T3 (en) |
PT (1) | PT3283043T (en) |
RU (1) | RU2710242C2 (en) |
WO (1) | WO2016166197A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10709850B2 (en) | 2018-06-15 | 2020-07-14 | James T. Doubet | Syringe adapter for medication |
ES1173259Y (en) * | 2016-12-15 | 2017-03-22 | Inst De Tecnologia Y Estetica Pharma S L | IN SITU USE KIT TO GUARANTEE THE QUALITY OF A COSMETIC PRODUCT APPLICABLE TO LIVING BEINGS |
IT201700032091A1 (en) * | 2017-03-23 | 2018-09-23 | Bormioli Pharma S R L | REDUCER FOR SYRINGE |
FR3080368B1 (en) | 2018-04-20 | 2021-04-23 | Virbac | SHOCK PROTECTION DEVICE SUITABLE TO EQUIP A BOTTLE |
CN108685688B (en) * | 2018-06-12 | 2024-05-17 | 张家港众辉医用塑料科技有限公司 | Three-stage filtration aseptic liquid medicine package |
US20190388625A1 (en) * | 2018-06-15 | 2019-12-26 | James T. Doubet | Syringe adapter for medication |
US11103641B1 (en) * | 2020-04-26 | 2021-08-31 | Paul D. Doubet | Container adapter for removably attachable syringe |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB918161A (en) * | 1961-08-05 | 1963-02-13 | Millipore Filter Corp | Fluid sampling device |
US3654926A (en) * | 1969-11-17 | 1972-04-11 | Parke Davis & Co | Mixing vial |
US4230112A (en) * | 1978-08-07 | 1980-10-28 | Smith Philip E | Syringe-type liquid container dispenser adapter |
US4493348A (en) * | 1981-06-29 | 1985-01-15 | Pur/Acc Corporation | Method and apparatus for orally dispensing liquid medication |
US4743243A (en) * | 1984-01-03 | 1988-05-10 | Vaillancourt Vincent L | Needle with vent filter assembly |
IE57676B1 (en) | 1984-03-19 | 1993-02-24 | Abbott Lab | Drug delivery system |
US4834152A (en) | 1986-02-27 | 1989-05-30 | Intelligent Medicine, Inc. | Storage receptacle sealing and transfer apparatus |
USRE37243E1 (en) * | 1993-03-24 | 2001-06-26 | Portola Packaging, Inc. | Neck finish for a container and a matching registering multiple thread pattern in a flexible cap for engagement on said neck finish |
US5702019A (en) * | 1995-09-27 | 1997-12-30 | Becton Dickinson France S.A. | Vial having resealable membrane assembly activated by a medical delivery device |
US5924584A (en) | 1997-02-28 | 1999-07-20 | Abbott Laboratories | Container closure with a frangible seal and a connector for a fluid transfer device |
CA2262477C (en) | 1998-05-16 | 2008-02-12 | Bracco International B.V. | Multiple use universal stopper |
US6139534A (en) * | 2000-01-24 | 2000-10-31 | Bracco Diagnostics, Inc. | Vial access adapter |
SE517084C2 (en) * | 2000-08-10 | 2002-04-09 | Carmel Pharma Ab | Procedures and devices for aseptic preparation |
GB0226347D0 (en) | 2002-11-12 | 2002-12-18 | Boots Healthcare Int Ltd | Improvements in and relating to liquid dispensing |
FR2870827B3 (en) | 2004-06-01 | 2006-04-28 | Pharmaglass Sarl | PACKAGING AND DISPENSING ASSEMBLY OF A PRODUCT, IN PARTICULAR A PHARMACEUTICAL PRODUCT, BY DOSES FROM THE SYRINGE, AND CORRESPONDING DISTRIBUTION INSETR. |
FR2872137B1 (en) * | 2004-06-24 | 2009-01-23 | Thea Sa Lab | CONTAINER FOR THE CONDITIONING OF A LIQUID WITH A DROPPER FLOW DISTRIBUTOR WITH REVERSIBLE DEFORMATION BY AIR INTAKE |
US7731678B2 (en) * | 2004-10-13 | 2010-06-08 | Hyprotek, Inc. | Syringe devices and methods for mixing and administering medication |
US8167863B2 (en) * | 2006-10-16 | 2012-05-01 | Carefusion 303, Inc. | Vented vial adapter with filter for aerosol retention |
FR2928539B1 (en) | 2008-03-12 | 2012-02-24 | Vygon | INTERFACING DEVICE FOR PERFORATING BOTTLES FOR THE PREPARATION OF PERFUME FLUIDS |
US8034044B2 (en) * | 2008-04-04 | 2011-10-11 | B. Braun Melsungen Ag | Systems and methods for combining materials |
FR2930725B1 (en) * | 2008-04-30 | 2010-08-13 | Oreal | COMPOSITIONS BASED ON HYDROGEN PEROXIDE POLYMERIC COMPLEXES AND USES THEREOF |
US9775980B2 (en) * | 2008-09-23 | 2017-10-03 | Hospi Corporation | Valved enteral administration assembly |
RU85332U1 (en) * | 2009-03-03 | 2009-08-10 | Сергей Анатольевич Бабичев | SAMPLE OF CONTENT OF DENTAL POCKET AND / OR DENTAL FURNACE FOR MICROBIOLOGICAL RESEARCH |
DE102009040016B4 (en) * | 2009-09-04 | 2016-02-25 | Jan Willem Marinus Mijers | Device for the application of fluid medicaments |
US8651305B1 (en) * | 2009-09-30 | 2014-02-18 | Simplified Dosing Incorporated | Reclosable container closure |
US9296531B2 (en) * | 2010-01-12 | 2016-03-29 | Medela Holding Ag | Container with sealed cap and venting system |
JP2011212361A (en) * | 2010-04-01 | 2011-10-27 | Terumo Corp | Medicine administration device |
WO2012017547A1 (en) * | 2010-08-06 | 2012-02-09 | イーエヌ大塚製薬株式会社 | Check valve, three-way stopcock unit, and fluid substance transfer tool |
JP2013540564A (en) * | 2010-10-25 | 2013-11-07 | ユニバーシティ・オブ・カンザス | Drug contact device for preventing contamination of drug containers |
WO2012061353A1 (en) * | 2010-11-01 | 2012-05-10 | Ge Healthcare Limited | Asceptic dispenser |
SG192312A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
FR2993174B1 (en) | 2012-07-16 | 2014-07-25 | Rovipharm | DEVICE FOR SECURING THE DISTRIBUTION OF A LIQUID CONTAINED IN A BOTTLE |
-
2015
- 2015-04-17 FR FR1553442A patent/FR3035080B1/en not_active Expired - Fee Related
-
2016
- 2016-04-14 WO PCT/EP2016/058194 patent/WO2016166197A1/en active Application Filing
- 2016-04-14 JP JP2018505531A patent/JP2018512990A/en not_active Ceased
- 2016-04-14 PL PL16719282T patent/PL3283043T3/en unknown
- 2016-04-14 PT PT16719282T patent/PT3283043T/en unknown
- 2016-04-14 EP EP16719282.2A patent/EP3283043B1/en active Active
- 2016-04-14 CA CA2982935A patent/CA2982935A1/en not_active Abandoned
- 2016-04-14 CN CN201680035704.XA patent/CN107750225B/en not_active Expired - Fee Related
- 2016-04-14 MX MX2017013325A patent/MX2017013325A/en unknown
- 2016-04-14 RU RU2017136441A patent/RU2710242C2/en active
- 2016-04-14 ES ES16719282T patent/ES2745278T3/en active Active
- 2016-04-14 KR KR1020177033308A patent/KR20180008501A/en not_active Application Discontinuation
- 2016-04-14 US US15/567,220 patent/US11090226B2/en active Active
-
2017
- 2017-10-17 IL IL255082A patent/IL255082A0/en unknown
-
2018
- 2018-04-25 HK HK18105378.1A patent/HK1246256A1/en unknown
- 2018-07-10 HK HK18108953.8A patent/HK1249006A1/en unknown
-
2021
- 2021-09-06 JP JP2021144992A patent/JP2021184862A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR20180008501A (en) | 2018-01-24 |
HK1246256A1 (en) | 2018-09-07 |
US20180104150A1 (en) | 2018-04-19 |
JP2018512990A (en) | 2018-05-24 |
PT3283043T (en) | 2019-09-26 |
JP2021184862A (en) | 2021-12-09 |
CA2982935A1 (en) | 2016-10-20 |
MX2017013325A (en) | 2018-06-22 |
RU2017136441A (en) | 2019-05-17 |
PL3283043T3 (en) | 2020-03-31 |
ES2745278T3 (en) | 2020-02-28 |
IL255082A0 (en) | 2017-12-31 |
HK1249006A1 (en) | 2018-10-26 |
FR3035080A1 (en) | 2016-10-21 |
RU2710242C2 (en) | 2019-12-25 |
WO2016166197A1 (en) | 2016-10-20 |
EP3283043B1 (en) | 2019-06-12 |
FR3035080B1 (en) | 2019-08-09 |
US11090226B2 (en) | 2021-08-17 |
RU2017136441A3 (en) | 2019-07-29 |
CN107750225A (en) | 2018-03-02 |
CN107750225B (en) | 2019-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3283043B1 (en) | Sealing device for making it possible to collect a composition, packaging assembly comprising such a sealing device, collection and packaging methods | |
EP0366534B1 (en) | Package to change the composition of a liquid | |
JP4749572B2 (en) | Dispensing container plug structure | |
EP2990350A1 (en) | Dispensing device | |
WO1999036029A1 (en) | Sealed confinement device for connecting a container and means for delivering a substance | |
LU84334A1 (en) | DEVICE FOR PROVIDING STERILE SOLUTION AND ITS REPLACEMENT WITH AIR | |
CA2837816A1 (en) | Device for connection between a recipient and a container and method for assembling and using such a device | |
WO2000016730A1 (en) | Device for connecting a receptacle and a container and ready-for-use set comprising same | |
WO1990007318A1 (en) | Storage and transfer bottle designed for storing a component of a medicamental substance | |
EP3554451B1 (en) | Device for collecting a sample of a liquid contained in a container, associated container, and use of this container | |
EP2085068B1 (en) | Liquid-dispensing nozzle and liquid packaging and dispensing system comprising such a nozzle | |
EP0786419A1 (en) | Dosing bottle | |
EP1034772A1 (en) | Device for transfering a substance contained in a vial to a pouch containing a solute | |
WO1999010245A1 (en) | Mixing flask contacting two isolated constituents before they are drawn and injected into a syringe | |
FR2539109A1 (en) | LIQUID DISPENSER | |
US20090200260A1 (en) | Bottle closure assembly | |
EP3302651A1 (en) | Method for producing at least one reservoir assembly, injectable-product reservoir assembly for an injection pen and injection pen equipped with such an assembly | |
EP0283629B1 (en) | Packaging for extemporaneous preparations | |
KR20110106158A (en) | The port for intravenous bag being able to prevent spike escape | |
FR2772727A1 (en) | Non-return seal for container neck opening | |
EP3866747A1 (en) | Device for temporarily connecting two containers | |
EP2781895A1 (en) | Variable-dose dosing capsule | |
FR2665633A1 (en) | Improvements to receptacles holding sterile contents, in particular to flexible bags for medical use | |
EP2072416B1 (en) | Method for filling a container | |
EP1682056B1 (en) | Assembly for packaging and dispensing a liquid, comprising membrane microfilters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20171106 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1249006 Country of ref document: HK |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20190117 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1141649 Country of ref document: AT Kind code of ref document: T Effective date: 20190615 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016015192 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Ref document number: 3283043 Country of ref document: PT Date of ref document: 20190926 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20190905 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190912 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190912 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20190402781 Country of ref document: GR Effective date: 20191128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191012 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2745278 Country of ref document: ES Kind code of ref document: T3 Effective date: 20200228 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016015192 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
26N | No opposition filed |
Effective date: 20200313 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200224 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 1141649 Country of ref document: AT Kind code of ref document: T Effective date: 20190612 |
|
PG2D | Information on lapse in contracting state deleted |
Ref country code: IS |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200414 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20210318 Year of fee payment: 6 Ref country code: PT Payment date: 20210316 Year of fee payment: 6 Ref country code: NL Payment date: 20210312 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20210322 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20210414 Year of fee payment: 6 Ref country code: DE Payment date: 20210408 Year of fee payment: 6 Ref country code: FR Payment date: 20210429 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20210506 Year of fee payment: 6 Ref country code: CH Payment date: 20210426 Year of fee payment: 6 Ref country code: AT Payment date: 20210322 Year of fee payment: 6 Ref country code: BE Payment date: 20210421 Year of fee payment: 6 Ref country code: GB Payment date: 20210415 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190612 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602016015192 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20220501 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1141649 Country of ref document: AT Kind code of ref document: T Effective date: 20220414 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220414 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221014 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220501 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220414 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221103 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221107 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20230529 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220414 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220415 |